VRDN Insider Trading - Viridian Therapeutics, Inc.

발행주식수	110,427,682 shares
내부자 지분	15,272,836 shares
내부자 주주	13.83 %
전체 내부자	53

내부자 센티멘트 점수

내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

가장 높은 순위의 주식을 확인하세요

내부 경영진 센티멘트 점수

내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.

내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

가장 높은 순위의 주식을 확인하세요

주요 내부자 지표

이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.

예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.

내부자의 순 매입(순위)

1 ( )

404 out of 10948

내부자의 순 매입(Net Number of Insiders Buying)는 내부자 매수의 총 수에서 지난 90일 동안의 내부자 매도의 총 수를 뺀 값입니다. 여기에 백분위 순위가 표시됩니다(범위: 0~100%).

내부자가 매입한 플로트 비율 (순위)

1.066% ( )

109 out of 10786

"내부자가 매입한 플로트 비율(Percent of Float Bought by Insiders)"은 내부자가 매입한 주식의 총 수에서 내부자가 매도한 주식의 총 수를 뺀 값을 전체 플로트로 나눈 값에 100을 곱한 값입니다. * ((내부자가 매입한 주식의 총 수 - 내부자가 매도한 주식의 총 수) ÷ 전체 플로트) x 100

내부자 트레이딩 차트

Viridian Therapeutics, Inc. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.

내부자의 명단 및 이익 지표

아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.

See our leaderboard of most profitable insider traders.

내부자	소유 지분	주식 분할
Atlas Venture Fund VII L P 10% Owner - [10%]	6,285,160	419,011
Beetham Thomas W. Chief Operating Officer - [O]	13,361	13,361
Bruce Booth Director - [D]	1,351,090	90,073
Christopher Bowden	24,000
Cohen Steven A/sac Capital Mgmt Lp 10% Owner - [10%]	426,162	426,162
Thomas Ciulla Chief Medical Officer - [O]	762	762
John W Creecy Director - [D]	5,413,126	360,875
Diana Escolar	270,000
Fhmlsp, L.l.c. 10% Owner - [10%]	1,505,200	1,505,200
Fhmlsp, L.p. 10% Owner - [10%]	1,505,200	1,505,200
Fairmount Funds Management LLC Director, 10% Owner - [D] [10%]	5,090,928	5,090,928
Fairmount Healthcare Fund GP LLC Director - [D]	938,233	1,845,813
Fairmount Healthcare Fund II GP LLC Director - [D]	938,233	5,090,928
Fairmount Healthcare Fund II L.P. Director - [D]	938,233	5,090,928
Fairmount Healthcare Fund L.P. Director - [D]	938,233	1,845,813
Frazier Life Sciences Public Fund, L.P. 10% Owner - [10%]	1,505,200	1,505,200
David A Gonyer Director - [D]	1,899	1,899

내부자	소유 지분	주식 분할
Seth Harmon Chief Financial Officer - [O]	7,850	7,850
Peter Evan Harwin	24,000
Hatfield Jeffrey S.	24,000
Hughes Thomas E. Director - [D]	12,827	855
Kristian Humer	90,000
Robert Brian Johnson	0
Kevin Koch	24,000
Barrett Katz Chief Medical Officer - [O]	0	0
Tomas Kiselak	24,000
Peter Kolchinsky 10% Owner - [10%]	410,686	410,686
Alpha, Lllp Lebow 10% Owner - [10%]	4,465,258	4,465,258
Bennett S Lebow Director, 10% Owner - [D] [10%]	280,600	18,707
Kyle Lefkoff Director - [D]	463,473	30,898
Leverone Jason A. CFO, Treasurer & Secretary - [O]	48,829	3,255
Adam Scott Levy Chief Business Officer - [O]	10,540	703
Logos Global Master Fund LP 10% Owner - [10%]	550,000	550,000
Mahoney Stephen F. President and CEO, Director - [D] [O]	33,349	33,349
William Stuart Marshall President & CEO, Director - [D] [O]	270,646	18,043

내부자	소유 지분	주식 분할
Lara Meisner Chief Legal Officer - [O]	29,971	29,971
Arlene Morris	24,000
Scott Dunseth Myers Chief Executive Officer, Director - [D] [O]	259,500	259,500
Point72 Asset Management, L.P. 10% Owner - [10%]	426,162	426,162
Point72 Capital Advisors, Inc. 10% Owner - [10%]	426,162	426,162
Ra Capital Management, Llc 10% Owner - [10%]	410,686	410,686
RA Capital Healthcare Fund LP 10% Owner - [10%]	410,686	410,686
Paul D Rubin	87,000
Rauch Lee M.	900,000
Remeditex Ventures LLC 10% Owner - [10%]	5,413,126	360,875
Samuel D Riccitelli President & CEO, Director - [D] [O]	571,370	571,370
Tamara A Seymour CFO, Secretary, Treasurer - [O]	106,447	106,447
Douglas A Schuling Director - [D]	10,500	10,500
Shah Rajeev M. 10% Owner - [10%]	410,686	410,686
Robin L Smith Director - [D]	1,900	1,900
Joseph L Turner	24,000
Jennifer Tousignant Chief Legal Officer - [O]	3,494	3,494
Jonathan Violin Chief Executive Officer, Director - [D] [O]	480,905	480,905

Report errors via our new Insider Auditing Tool

내부자의 매입 내역 추적: 단기 이익 분석

이 섹션에서는 VRDN / Viridian Therapeutics, Inc.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.

거래일	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고에서 가격	최고 이익 ($)	최고 수익률 (%)
2026-05-11	Fairmount Funds Management LLC	1,176,470	17.0000	1,176,470	17.0000	19,999,990	10	17.6900	811,764	4.06
2025-10-23	Fairmount Funds Management LLC	454,545	22.0000	454,545	22.0000	9,999,990
2024-09-27	Mahoney Stephen F.	21,400	23.3300	21,400	23.3300	499,262
2024-09-27	Beetham Thomas W.	5,000	23.4100	5,000	23.4100	117,050
2024-09-13	Fairmount Funds Management LLC	1,600,000	18.7500	1,600,000	18.7500	30,000,000
2024-01-22	Fairmount Funds Management LLC	476,190	21.0000	476,190	21.0000	9,999,990
2023-04-12	Myers Scott Dunseth	4,000	25.3697	4,000	25.3697	101,479
2023-03-13	Myers Scott Dunseth	5,500	29.1499	5,500	29.1499	160,324
2022-08-17	Fairmount Funds Management LLC	425,531	23.5000	425,531	23.5000	9,999,978

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

VRDN / Viridian Therapeutics, Inc. Insider Trades

내부자 매매의 실적: 단기 손실 분석

이 섹선에서는 VRDN / Viridian Therapeutics, Inc.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.

거래일	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
2025-12-31	Tousignant Jennifer	2,272	31.1600	2,272	31.1600	70,796	119	13.3000	-40,577	-57.32
2023-06-16	Meisner Lara	27	28.3500	27	28.3500	765
2023-06-06	Meisner Lara	5,126	25.0200	5,126	25.0200	128,253
2023-06-05	Meisner Lara	499	25.0300	499	25.0300	12,490
2023-02-02	Violin Jonathan	50,000	36.8000	50,000	36.8000	1,840,000
2023-02-02	Violin Jonathan	50,000	36.8000	50,000	36.8000	1,840,000
2022-06-01	Violin Jonathan	30,000	12.2000	30,000	12.2000	366,000
2022-05-02	Violin Jonathan	30,000	13.0400	30,000	13.0400	391,200
2022-04-04	Violin Jonathan	3,600	18.9300	3,600	18.9300	68,148

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

거래 내역

전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.

보고일	거래일	양식	내부자	티커	증권 소유권	코드	직접	행사 가격	단위 가격	단위 변동	가치 변동 (단위: 1,000)	잔여 옵션	잔여 주식
2026-05-13	2026-05-11	4	Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P.	VRDN	Common Stock	P - Purchase	I		17.0000	1,176,470	20,000		5,090,928
2026-03-09	2026-03-03	4/A	Harmon Seth	VRDN	Common Stock	F - Taxes	D		30.1900	-2,031	-61		7,850
2026-03-09	2026-03-03	4/A	Beetham Thomas W.	VRDN	Common Stock	F - Taxes	D		30.1900	-3,048	-92		13,361
2026-03-09	2026-03-03	4/A	Mahoney Stephen F.	VRDN	Common Stock	F - Taxes	D		30.1900	-7,408	-224		33,349
2026-03-09	2026-03-03	4/A	Tousignant Jennifer	VRDN	Common Stock	F - Taxes	D		30.1900	-1,675	-51		3,494
2026-03-04	2026-03-03	4	Tousignant Jennifer	VRDN	Common Stock	F - Taxes	D		29.3200	-1,724	-51		3,445
2026-03-04	2026-03-03	4	Tousignant Jennifer	VRDN	Common Stock	M - Exercise	D			5,169			5,169
2026-03-04	2026-03-03	4	Harmon Seth	VRDN	Common Stock	F - Taxes	D		29.3200	-2,091	-61		7,790
2026-03-04	2026-03-03	4	Harmon Seth	VRDN	Common Stock	M - Exercise	D			6,267			9,881
2026-03-04	2026-03-03	4	Beetham Thomas W.	VRDN	Common Stock	F - Taxes	D		29.3200	-3,138	-92		13,271
2026-03-04	2026-03-03	4	Beetham Thomas W.	VRDN	Common Stock	M - Exercise	D			9,409			16,409
2026-03-04	2026-03-03	4	Mahoney Stephen F.	VRDN	Common Stock	F - Taxes	D		29.3200	-7,627	-224		33,130
2026-03-04	2026-03-03	4	Mahoney Stephen F.	VRDN	Common Stock	M - Exercise	D			18,357			40,757
2026-01-02	2025-12-31	4	Tousignant Jennifer	VRDN	Common Stock	S - Sale	D		31.1600	-2,272	-71		0
2025-10-27	2025-10-23	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	P - Purchase	I		22.0000	454,545	10,000		3,914,458
2025-06-11	2025-06-10	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	M - Exercise	I		12.3100	12,500	154		3,459,913
2025-06-11	2025-06-09	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	M - Exercise	I		7.8000	1,600	12		3,447,413
2024-09-30	2024-09-27	4	Beetham Thomas W.	VRDN	Common Stock	P - Purchase	D		23.4100	5,000	117		6,000
2024-09-30	2024-09-27	4	Mahoney Stephen F.	VRDN	Common Stock	P - Purchase	D		23.3300	21,400	499		21,400
2024-09-17	2024-09-13	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	P - Purchase	I		18.7500	1,600,000	30,000		3,445,813
2024-04-01	2024-03-28	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	J - Other	I			5,859			1,845,813
2024-04-01	2024-03-28	4	Fairmount Funds Management LLC Fairmount Healthcare Fund LP	VRDN	Common Stock	J - Other	I			-5,859			0
2024-01-24	2024-01-22	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	P - Purchase	I		21.0000	476,190	10,000		1,839,954
2024-01-12		3	Ciulla Thomas	VRDN	Common Stock		D						762
2023-06-20	2023-06-16	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.3500	-27	-1		29,971
2023-06-20	2023-06-16	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	27	1		29,998
2023-06-20	2023-06-15	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.0200	-2,269	-64		29,971
2023-06-20	2023-06-15	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	2,269	52		32,240
2023-06-06	2023-06-06	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		25.0200	-5,126	-128		29,971
2023-06-06	2023-06-06	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		18.5100	5,126	95		35,097
2023-06-06	2023-06-05	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		25.0300	-499	-12		29,971
2023-06-06	2023-06-05	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		18.5100	499	9		30,470
2023-06-06	2023-06-02	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		24.2100	-1,875	-45		29,971
2023-06-06	2023-06-02	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		14.0000	1,875	26		31,846
2023-04-12	2023-04-12	4	Myers Scott Dunseth	VRDN	Common Stock	P - Purchase	D		25.3697	4,000	101		259,500
2023-03-13	2023-03-13	4	Myers Scott Dunseth	VRDN	Common Stock	P - Purchase	D		29.1499	5,500	160		255,500
2023-03-10	2023-03-09	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		29.0700	-29,971	-871		0
2023-02-07	2023-02-06	4	Myers Scott Dunseth	VRDN	Common Stock	A - Award	D			250,000			250,000
2023-02-07	2023-02-02	4/A	Violin Jonathan	VRDN	Common Stock	S - Sale	D		36.8000	-50,000	-1,840		480,905
2023-02-07	2023-02-02	4/A	Violin Jonathan	VRDN	Common Stock	M - Exercise	D		0.1500	50,000	8		530,905
2023-02-03	2023-02-02	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		36.8000	-50,000	-1,840		430,905
2023-01-25	2023-01-23	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		35.6600	-6,843	-244		0
2023-01-25	2023-01-23	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		14.0000	1,872	26		6,843
2023-01-25	2023-01-23	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	4,971	114		4,971
2023-01-18	2023-01-17	4	Katz Barrett	VRDN	Common Stock	S - Sale	D		37.2100	-24,853	-925		0
2023-01-18	2023-01-17	4	Katz Barrett	VRDN	Common Stock	M - Exercise	D		23.0300	24,853	572		24,853
2023-01-18	2023-01-13	4	Katz Barrett	VRDN	Common Stock	S - Sale	D		37.0100	-4,147	-153		0
2023-01-18	2023-01-13	4	Katz Barrett	VRDN	Common Stock	M - Exercise	D		23.0300	4,147	96		4,147
2023-01-11	2023-01-10	4	Katz Barrett	VRDN	Common Stock	S - Sale	D		35.3000	-47,377	-1,672		0
2023-01-11	2023-01-10	4	Katz Barrett	VRDN	Common Stock	M - Exercise	D		23.0300	47,377	1,091		47,377
2023-01-11	2023-01-09	4	Katz Barrett	VRDN	Common Stock	S - Sale	D		33.0400	-12,623	-417		0
2023-01-11	2023-01-09	4	Katz Barrett	VRDN	Common Stock	M - Exercise	D		23.0300	12,623	291		12,623
2022-12-22	2022-12-21	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		29.1900	-16,326	-477		0
2022-12-22	2022-12-21	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	16,326	376		16,326
2022-12-22	2022-12-20	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.0700	-600	-17		0
2022-12-22	2022-12-20	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	600	14		600
2022-12-19	2022-12-16	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.4400	-1,297	-37		0
2022-12-19	2022-12-16	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	1,297	30		1,297
2022-12-19	2022-12-15	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.0800	-300	-8		0
2022-12-19	2022-12-15	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	300	7		300
2022-12-14	2022-12-14	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.1200	-15,656	-440		0
2022-12-14	2022-12-14	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	15,656	361		15,656
2022-12-14	2022-12-12	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		28.0500	-600	-17		0
2022-12-14	2022-12-12	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		23.0300	600	14		600
2022-11-16	2022-11-15	4	Meisner Lara	VRDN	Common Stock	S - Sale	D		22.0500	-8,125	-179		0
2022-11-16	2022-11-15	4	Meisner Lara	VRDN	Common Stock	M - Exercise	D		14.0000	8,125	114		8,125
2022-08-19	2022-08-17	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	P - Purchase	I		23.5000	425,531	10,000		1,363,764
2022-06-02	2022-06-01	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		12.2000	-30,000	-366		480,905
2022-05-04	2022-05-02	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		13.0400	-30,000	-391		510,905
2022-04-05	2022-04-04	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		18.9300	-3,600	-68		540,905
2022-04-05	2022-04-01	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		18.9200	-26,400	-499		544,505
2022-03-03	2022-03-02	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		17.3600	-11,106	-193		570,905
2022-03-03	2022-03-01	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		17.8200	-18,894	-337		582,011
2022-02-03	2022-02-02	4	Humer Kristian	VRDN	Stock Option (Right to Buy)	A - Award	D	18.51		90,000		90,000
2022-02-03	2022-02-02	4	Katz Barrett	VRDN	Stock Option (Right to Buy)	A - Award	D	18.51		110,000		110,000
2022-02-03	2022-02-02	4	Meisner Lara	VRDN	Stock Option (Right to Buy)	A - Award	D	18.51		90,000		90,000
2022-02-03	2022-02-03	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		19.1600	-909	-17		600,905
2022-02-03	2022-02-02	4	Violin Jonathan	VRDN	Stock Option (Right to Buy)	A - Award	D	18.51		280,000		280,000
2022-02-03	2022-02-02	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		18.4700	-12,340	-228		601,814
2022-02-03	2022-02-01	4	Violin Jonathan	VRDN	Common Stock	S - Sale	D		19.5500	-16,751	-327		614,154
2022-01-03	2021-12-31	4	Humer Kristian	VRDN	Stock Option (Right to Buy)	A - Award	D	19.77		121,371		121,371
2021-12-10	2021-12-08	4	Violin Jonathan	VRDN	Series A Non-Voting Convertible Preferred Stock	C - Conversion	D			-9,413		0
2021-12-10	2021-12-08	4	Violin Jonathan	VRDN	Common Stock	C - Conversion	D			627,564			630,905
2021-09-28	2021-09-23	4	Frazier Life Sciences Public Fund, L.P.	VRDN	Common Stock	P - Purchase	D		11.0000	200,000	2,200		1,505,200
2021-09-23	2021-09-21	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	VRDN	Common Stock	P - Purchase	I		11.0000	909,000	9,999		938,233
2021-08-26		3	FHMLSP, L.P.	VRDN	Common Stock		D						1,305,200
2021-07-27	2021-07-26	4	Humer Kristian	VRDN	Stock Option (Right to Buy)	A - Award	D	17.09		360,000		360,000
2021-07-15	2021-07-14	4	Moses Jennifer K.	VRDN	Stock Option (Right to Buy)	A - Award	D	17.88		25,000		25,000
2021-06-16	2021-06-03	4	Kiselak Tomas	VRDN	Stock Option (Right to Buy)	A - Award	D	16.60		12,500		12,500
2021-06-16	2021-06-03	4	Harwin Peter Evan	VRDN	Stock Option (Right to Buy)	A - Award	D	16.60		12,500		12,500
2021-06-16	2021-06-03	4	Morris Arlene	VRDN	Stock Option (Right to Buy)	A - Award	D	16.60		12,500		12,500
2021-02-08	2021-02-04	4	TURNER JOSEPH L	VRDN	Director Stock Option (Right to Buy)	A - Award	D	20.50		25,000		25,000
2021-02-08	2021-02-04	4	Harwin Peter Evan	VRDN	Director Stock Option (Right to Buy)	A - Award	D	20.50		25,000		25,000
2021-02-08	2021-02-04	4	Hatfield Jeffrey S.	VRDN	Director Stock Option (Right to Buy)	A - Award	D	20.50		25,000		25,000
2021-02-08	2021-02-04	4	Kiselak Tomas	VRDN	Director Stock Option (Right to Buy)	A - Award	D	20.50		25,000		25,000
2021-02-08	2021-02-04	4	Morris Arlene	VRDN	Director Stock Option (Right to Buy)	A - Award	D	20.50		25,000		25,000
2021-01-21	2021-01-18	4	Katz Barrett	VRDN	Employee Stock Option (right to buy)	A - Award	D	23.03		356,000		356,000
2021-01-20	2021-01-18	4	Leverone Jason A.	VRDN	Employee Stock Option (right to buy)	A - Award	D	23.03		311,785		311,785
2021-01-20	2021-01-18	4	Violin Jonathan	VRDN	Employee Stock Option (right to buy)	A - Award	D	23.03		800,075		800,075
2021-01-19	2021-01-18	4	Rauch Lee M.	MGEN	Employee Stock Option (right to buy)	A - Award	D	23.03		15,000		15,000
2020-12-17		3	Shah Rajeev M.	MGEN	Common Stock		I						410,686
2020-11-20		3	COHEN STEVEN A/SAC CAPITAL MGMT LP See footnotes	MGEN	Common Stock		I						426,162
2020-11-16	2020-11-13	4	Logos Global Master Fund LP	MGEN	Common Stock	P - Purchase	D		14.8389	126,667	1,880		550,000
2020-11-16	2020-11-09	4	Logos Global Master Fund LP	MGEN	Common Stock	P - Purchase	D		1.1641	100,000	116		6,350,000
2020-11-16	2020-11-09	4	Logos Global Master Fund LP	MGEN	Common Stock	P - Purchase	D		1.0979	250,000	274		6,250,000
2020-11-16		3	Logos Global Master Fund LP	MGEN	Common Stock		D						6,000,000
2020-10-30	2020-10-27	4	Violin Jonathan	MGEN	Series A Non-Voting Convertible Preferred Stock	J - Other	D			9,413		9,413
2020-10-30	2020-10-27	4	Violin Jonathan	MGEN	Employee Stock Option (Right to Buy)	J - Other	D	0.01		4,338,079		4,338,079
2020-10-30	2020-10-27	4	Violin Jonathan	MGEN	Common Stock	J - Other	D			50,124			50,124
2020-10-30		3	Violin Jonathan	MGEN	Common Stock		D						50,124
2020-10-30	2020-10-30	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	MGEN	Series A Non-Voting Convertible Preferred Stock	P - Purchase	I		465.9600	28,843	13,440	111,192
2020-10-30	2020-10-30	4	Fairmount Funds Management LLC Fairmount Healthcare Fund LP	MGEN	Series A Non-Voting Convertible Preferred Stock	P - Purchase	I		465.9600	5,494	2,560	21,999
2020-10-30		3	Fairmount Healthcare Fund II L.P. By funds	MGEN	Common Stock		I						526,393
2020-10-29	2020-10-27	4	Kiselak Tomas	MGEN	Director Stock Option (Right to Buy)	A - Award	D	0.52		24,000		24,000
2020-10-29	2020-10-27	4	Harwin Peter Evan	MGEN	Director Stock Option (Right to Buy)	A - Award	D	0.52		24,000		24,000
2020-10-29	2020-10-27	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	MGEN	Series A Non-Voting Convertible Preferred Stock	J - Other	I			82,349		82,349
2020-10-29	2020-10-27	4	Fairmount Funds Management LLC Fairmount Healthcare Fund LP	MGEN	Series A Non-Voting Convertible Preferred Stock	J - Other	I			16,505		16,505
2020-10-29	2020-10-27	4	Fairmount Funds Management LLC Fairmount Healthcare Fund II LP	MGEN	Common Stock	J - Other	I			438,502			438,502
2020-10-29	2020-10-27	4	Fairmount Funds Management LLC Fairmount Healthcare Fund LP	MGEN	Common Stock	J - Other	I			87,891			87,891
2020-09-17	2020-09-13	4/A	Rauch Lee M.	MGEN	Stock Option (right to buy)	A - Award	D	0.91		900,000		900,000
2020-09-15	2020-09-14	4	Rauch Lee M.	MGEN	Stock Option (right to buy)	A - Award	D	0.91		900,000		900,000
2020-05-22	2020-05-21	4	Hatfield Jeffrey S.	MGEN	Stock Option (right to buy)	A - Award	D	0.63		24,000		24,000
2020-05-22	2020-05-21	4	TURNER JOSEPH L	MGEN	Stock Option (right to buy)	A - Award	D	0.63		24,000		24,000
2020-05-22	2020-05-21	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	0.63		24,000		24,000
2020-05-22	2020-05-21	4	KOCH KEVIN	MGEN	Stock Option (right to buy)	A - Award	D	0.63		24,000		24,000
2020-05-22	2020-05-21	4	Morris Arlene	MGEN	Stock Option (right to buy)	A - Award	D	0.63		24,000		24,000
2020-05-22	2020-05-21	4	Bowden Christopher	MGEN	Stock Option (right to buy)	A - Award	D	0.63		24,000		24,000
2020-03-17	2020-03-13	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	M - Exercise	D	0.57		-11,249		0
2020-03-17	2020-03-13	4	Leverone Jason A.	MGEN	Common Stock	M - Exercise	D		0.5700	11,249	6		48,829
2020-02-14	2020-02-12	4	Marshall William Stuart	MGEN	Stock Option (right to buy)	A - Award	D	0.80		464,000		464,000
2020-02-14	2020-02-12	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	A - Award	D	0.80		185,000		185,000
2020-02-14	2020-02-12	4	Escolar Diana	MGEN	Stock Option (right to buy)	A - Award	D	0.80		270,000		270,000
2020-02-13	2019-08-21	5	Marshall William Stuart	MGEN	Common Stock	A - Award	D		1.1390	1,250	1		270,646
2020-02-13	2019-02-21	5	Marshall William Stuart	MGEN	Common Stock	A - Award	D		2.4565	1,250	3		269,396
2019-08-23	2019-08-23	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	M - Exercise	D	0.57		-3,093		0
2019-08-23	2019-08-23	4	Leverone Jason A.	MGEN	Common Stock	M - Exercise	D		0.5700	3,093	2		36,330
2019-06-21	2019-06-19	4	Bowden Christopher	MGEN	Stock Option (right to buy)	A - Award	D	2.36		12,000		12,000
2019-06-21	2019-06-19	4	Hatfield Jeffrey S.	MGEN	Stock Option (right to buy)	A - Award	D	2.36		12,000		12,000
2019-06-21	2019-06-19	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	2.36		12,000		12,000
2019-06-21	2019-06-19	4	KOCH KEVIN	MGEN	Stock Option (right to buy)	A - Award	D	2.36		12,000		12,000
2019-06-21	2019-06-19	4	Morris Arlene	MGEN	Stock Option (right to buy)	A - Award	D	2.36		12,000		12,000
2019-06-21	2019-06-19	4	TURNER JOSEPH L	MGEN	Stock Option (right to buy)	A - Award	D	2.36		12,000		12,000
2019-04-05	2019-04-03	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	2.99		10,106		10,106
2019-02-08	2019-02-06	4	Marshall William Stuart	MGEN	Stock Option (right to buy)	A - Award	D	2.96		232,000		232,000
2019-02-08	2019-02-06	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	A - Award	D	2.96		75,000		75,000
2019-02-08	2019-02-06	4	Levy Adam Scott	MGEN	Stock Option (right to buy)	A - Award	D	2.96		74,000		74,000
2019-02-08	2019-02-06	4	RUBIN PAUL D	MGEN	Stock Option (right to buy)	A - Award	D	2.96		87,000		87,000
2018-10-12	2018-10-11	4	Hughes Thomas E.	MGEN	Common Stock	P - Purchase	D		4.7697	10,000	48		12,827
2018-08-09	2018-08-07	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	M - Exercise	D	0.57		-29,530		0
2018-08-09	2018-08-07	4	Leverone Jason A.	MGEN	Common Stock	M - Exercise	D		0.5700	29,530	17		30,737
2018-06-28	2018-06-27	4	Morris Arlene	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-06-28	2018-06-27	4	TURNER JOSEPH L	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-06-28	2018-06-27	4	Booth Bruce	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-06-28	2018-06-27	4	Bowden Christopher	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-06-28	2018-06-27	4	Hatfield Jeffrey S.	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-06-28	2018-06-27	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-06-28	2018-06-27	4	KOCH KEVIN	MGEN	Stock Option (right to buy)	A - Award	D	6.46		12,000		12,000
2018-02-15	2018-02-13	4	Marshall William Stuart	MGEN	Stock Option (right to buy)	M - Exercise	D	0.57		-115,818		0
2018-02-15	2018-02-13	4	Marshall William Stuart	MGEN	Common Stock	M - Exercise	D		0.5700	115,818	66		265,646
2018-02-13	2018-02-13	4	Booth Bruce	MGEN	Common Stock	P - Purchase	I		5.5000	545,454	3,000		1,351,090
2018-02-13	2018-02-13	4	Levy Adam Scott	MGEN	Common Stock	P - Purchase	D		5.5000	9,090	50		10,540
2018-02-02	2018-01-31	4	Marshall William Stuart	MGEN	Stock Option (right to buy)	A - Award	D	7.50		245,000		245,000
2018-02-02	2018-01-31	4	RUBIN PAUL D	MGEN	Stock Option (right to buy)	A - Award	D	7.50		85,000		85,000
2018-02-02	2018-01-31	4	Levy Adam Scott	MGEN	Stock Option (right to buy)	A - Award	D	7.50		80,000		80,000
2018-02-02	2018-01-31	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	A - Award	D	7.50		75,000		75,000
2018-01-05	2018-01-03	4	Booth Bruce	MGEN	Stock Option (right to buy)	A - Award	D	9.72		10,191		10,191
2018-01-05	2018-01-03	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	9.72		3,426		3,426
2017-12-22	2017-12-20	4	Hughes Thomas E.	MGEN	Common Stock	S - Sale	D		8.0000	-12,000	-96		2,827
2017-06-30	2017-06-28	4	KOCH KEVIN	MGEN	Stock Option (right to buy)	A - Award	D	12.06		12,000		12,000
2017-06-30	2017-06-28	4	LEFKOFF KYLE	MGEN	Stock Option (right to buy)	A - Award	D	12.06		12,000		12,000
2017-06-30	2017-06-28	4	Booth Bruce	MGEN	Stock Option (right to buy)	A - Award	D	12.06		12,000		12,000
2017-06-30	2017-06-28	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	12.06		12,000		12,000
2017-06-30	2017-06-28	4	Creecy John W	MGEN	Stock Option (right to buy)	A - Award	D	12.06		12,000		12,000
2017-06-30	2017-06-28	4	TURNER JOSEPH L	MGEN	Stock Option (right to buy)	A - Award	D	12.06		12,000		12,000
2017-06-23	2017-06-22	4	Levy Adam Scott	MGEN	Common Stock	P - Purchase	D		7.5500	200	2		200
2017-03-28	2017-03-24	4	Booth Bruce	MGEN	Stock Option (right to buy)	A - Award	D	11.80		6,844		6,844
2017-03-28	2017-03-24	4	Hughes Thomas E.	MGEN	Stock Option (right to buy)	A - Award	D	11.80		1,191		1,191
2017-03-28	2017-03-24	4	Hughes Thomas E.	MGEN	Common Stock	A - Award	D			778			14,840
2017-03-13	2017-03-10	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		14.3118	-3,300	-47		463,473
2017-03-13	2017-03-09	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		14.3846	-2,500	-36		466,773
2017-03-08	2017-03-08	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		14.7028	-5,000	-74		469,273
2017-03-08	2017-03-06	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		16.2398	-608	-10		474,273
2017-03-08	2017-03-06	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		15.7144	-9,392	-148		474,881
2017-02-28	2017-02-28	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		13.5430	-2,258	-31		484,273
2017-02-28	2017-02-27	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		13.7910	-1,500	-21		486,531
2017-02-28	2017-02-24	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		14.0388	-6,500	-91		488,031
2017-02-24	2017-02-23	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		13.6477	-1,800	-25		494,531
2017-02-24	2017-02-22	4	LEFKOFF KYLE	MGEN	Common Stock	S - Sale	I		14.3554	-4,102	-59		496,331
2017-02-16	2017-02-16	4	RUBIN PAUL D	MGEN	Stock Option (right to buy)	A - Award	D	11.01		87,500		87,500
2017-02-16	2017-02-16	4	Leverone Jason A.	MGEN	Stock Option (right to buy)	A - Award	D	11.01		77,500		77,500
2017-02-16	2017-02-16	4	Marshall William Stuart	MGEN	Stock Option (right to buy)	A - Award	D	11.01		200,000		200,000
2017-02-16	2017-02-16	4	Levy Adam Scott	MGEN	Stock Option (right to buy)	A - Award	D	11.01		87,500		87,500
2017-02-13		3	Creecy John W	MGEN	Common Stock		I						5,413,126
2017-02-13		3	Creecy John W	MGEN	Common Stock		I						5,413,126
2017-02-13		3	Remeditex Ventures LLC	MGEN	Common Stock		D						5,413,126
2017-02-13		3	Remeditex Ventures LLC	MGEN	Common Stock		D						5,413,126
2017-02-13		3	Atlas Venture Fund VII L P	MGEN	Common Stock		D						6,285,160
2017-02-13		3	Atlas Venture Fund VII L P	MGEN	Common Stock		D						6,285,160
2017-02-13		3	LEFKOFF KYLE See Footnotes	MGEN	Common Stock		I						2,608,303
2017-02-13		3	LEFKOFF KYLE See Footnotes	MGEN	Common Stock		I						2,608,303
2017-02-13		3	LEFKOFF KYLE See Footnotes	MGEN	Common Stock		I						3,715,307
2017-02-13		3	LEFKOFF KYLE See Footnotes	MGEN	Common Stock		I						3,715,307
2017-02-13		3	Marshall William Stuart	MGEN	Common Stock		D						297,156
2017-02-13		3	Marshall William Stuart	MGEN	Common Stock		D						297,156
2017-02-13		3	Booth Bruce	MGEN	Common Stock		I						7,090,796
2017-02-13		3	Booth Bruce	MGEN	Common Stock		I						7,090,796
2017-02-13		3	Booth Bruce	MGEN	Common Stock		I						4,753,852
2017-02-13		3	Booth Bruce	MGEN	Common Stock		I						4,753,852
2017-02-13		3	Hughes Thomas E.	MGEN	Common Stock		D						28,124
2017-02-13		3	Hughes Thomas E.	MGEN	Common Stock		D						28,124
2017-02-13	2017-02-13	4	LEBOW BENNETT S	MGEN	Unsecured Demand Promissory Note	M - Exercise	D	5.39				0
2017-02-13	2017-02-13	4	LEBOW BENNETT S	MGEN	Unsecured Demand Promissory Note	A - Award	D	5.39
2017-02-13	2017-02-13	4	LEBOW BENNETT S	MGEN	Common Stock	M - Exercise	D		5.3900	279,067	1,504		280,600
2017-02-08	2017-02-08	4	Gonyer David A	SGNL	Stock Option (Right to Buy)	M - Exercise	D	7.65		-1,200		0
2017-02-08	2017-02-08	4	Gonyer David A	SGNL	Common Stock	M - Exercise	D		7.6500	1,200	9		1,899
2017-02-07	2017-02-03	4	Smith Robin L	SGNL	Stock Option (Right to Buy)	M - Exercise	D	7.65		-1,200		0
2017-02-07	2017-02-03	4	Smith Robin L	SGNL	Common Stock	M - Exercise	D		7.6500	1,200	9		1,900
2017-02-07	2017-02-03	4	LEBOW BENNETT S	SGNL	Stock Option (Right to Buy)	M - Exercise	D	7.65		-1,200		0
2017-02-07	2017-02-03	4	LEBOW BENNETT S	SGNL	Common Stock	M - Exercise	D		7.6500	1,200	9		1,533
2016-11-02	2016-10-31	4	Riccitelli Samuel D	SGNL	Restricted Stock Units	M - Exercise	D	0.00		-200,000		0
2016-11-02	2016-10-31	4	Riccitelli Samuel D	SGNL	Common Stock	F - Taxes	D		0.3600	-103,160	-37		571,370
2016-11-02	2016-10-31	4	Riccitelli Samuel D	SGNL	Common Stock	M - Exercise	D			200,000			674,530
2016-11-02	2016-10-31	4	SEYMOUR TAMARA A	SGNL	Restricted Stock Units	M - Exercise	D			-100,000		0
2016-11-02	2016-10-31	4	SEYMOUR TAMARA A	SGNL	Restricted Stock Units	M - Exercise	D			-46,000		0
2016-11-02	2016-10-31	4	SEYMOUR TAMARA A By Trust	SGNL	Common Stock	F - Taxes	I		0.3600	-45,580	-16		106,447
2016-11-02	2016-10-31	4	SEYMOUR TAMARA A By Trust	SGNL	Common Stock	M - Exercise	I			100,000			152,027
2016-11-02	2016-10-31	4	SEYMOUR TAMARA A By Trust	SGNL	Common Stock	F - Taxes	I		0.3600	-20,967	-8		52,027
2016-11-02	2016-10-31	4	SEYMOUR TAMARA A By Trust	SGNL	Common Stock	M - Exercise	I			46,000			72,994
2016-08-10	2016-08-08	4	SEYMOUR TAMARA A	SGNL	Restricted Stock Units	M - Exercise	D			-23,000		46,000
2016-08-10	2016-08-08	4	SEYMOUR TAMARA A By Trust	SGNL	Common Stock	F - Taxes	I		0.4850	-10,484	-5		26,994
2016-08-10	2016-08-08	4	SEYMOUR TAMARA A By Trust	SGNL	Common Stock	M - Exercise	I			23,000			37,478
2016-06-30	2016-06-28	4	Riccitelli Samuel D	SGNL	Restricted Stock Units	M - Exercise	D	0.00		-124,251		0
2016-06-30	2016-06-28	4	Riccitelli Samuel D	SGNL	Common Stock	F - Taxes	D		0.4600	-64,835	-30		474,530
2016-06-30	2016-06-28	4	Riccitelli Samuel D	SGNL	Common Stock	M - Exercise	D			124,251			539,365
2016-06-20	2016-06-15	4	Gonyer David A	SGNL	Stock Option (Right to Buy)	A - Award	D	0.51		18,000		18,000
2016-06-20	2016-06-15	4	Schuling Douglas A	SGNL	Stock Option (Right to Buy)	A - Award	D	0.51		18,000		18,000
2016-06-20	2016-06-15	4	Smith Robin L	SGNL	Stock Option (Right to Buy)	A - Award	D	0.51		18,000		18,000
2016-06-20	2016-06-15	4	LEBOW BENNETT S	SGNL	Stock Option (Right to Buy)	A - Award	D	0.51		18,000		18,000
2016-05-19	2016-03-28	4	Riccitelli Samuel D	SGNL	Restricted Stock Units	A - Award	D	0.00		200,000		200,000
2016-05-19	2016-03-28	4	SEYMOUR TAMARA A	SGNL	Restricted Stock Units	A - Award	D	0.00		100,000		100,000
2016-02-12	2016-02-11	4	Riccitelli Samuel D	SGNL	Restricted Stock Units	M - Exercise	D	0.00		-124,252		124,251
2016-02-12	2016-02-11	4	Riccitelli Samuel D	SGNL	Common Stock	F - Taxes	D		0.4600	-54,268	-25		415,114
2016-02-12	2016-02-11	4	Riccitelli Samuel D	SGNL	Common Stock	M - Exercise	D			124,252			469,382
2015-11-23	2015-11-20	4	Riccitelli Samuel D	SGNL	Common Stock	P - Purchase	D		0.8000	7,000	6		345,130
2015-11-23	2015-11-19	4	Riccitelli Samuel D	SGNL	Common Stock	P - Purchase	D		0.7800	7,000	5		338,130
2015-08-14	2015-08-12	4	SEYMOUR TAMARA A	SGNL	Employee Stock Option (Right to Buy)	A - Award	D	1.57		60,000		60,000
2015-08-10	2015-08-06	4	Gonyer David A	SGNL	Stock Option (Right to Buy)	A - Award	D	1.62		18,000		18,000
2015-08-10	2015-08-06	4	Gonyer David A	SGNL	Restricted Stock Units	M - Exercise	D			-4,125		0
2015-08-10	2015-08-06	4	Gonyer David A	SGNL	Common Stock	A - Award	D			5,000			10,500
2015-08-10	2015-08-06	4	Gonyer David A	SGNL	Common Stock	M - Exercise	D			4,125			5,500
2015-08-10	2015-08-06	4	Schuling Douglas A	SGNL	Stock Option (Right to Buy)	A - Award	D	1.62		18,000		18,000
2015-08-10	2015-08-06	4	Schuling Douglas A	SGNL	Restricted Stock Units	M - Exercise	D			-4,125		0
2015-08-10	2015-08-06	4	Schuling Douglas A	SGNL	Common Stock	A - Award	D			5,000			10,500
2015-08-10	2015-08-06	4	Schuling Douglas A	SGNL	Common Stock	M - Exercise	D			4,125			5,500
2015-08-10	2015-08-06	4	Smith Robin L	SGNL	Stock Option (Right to Buy)	A - Award	D	1.62		18,000		18,000
2015-08-10	2015-08-06	4	Smith Robin L	SGNL	Restricted Stock Units	M - Exercise	D			-4,125		0
2015-08-10	2015-08-06	4	Smith Robin L	SGNL	Common Stock	A - Award	D			5,000			10,500
2015-08-10	2015-08-06	4	Smith Robin L	SGNL	Common Stock	M - Exercise	D			4,125			5,500
2015-08-10	2015-08-06	4	LEBOW BENNETT S	SGNL	Stock Option (Right to Buy)	A - Award	D	1.62		18,000		18,000
2015-08-10	2015-08-06	4	LEBOW BENNETT S	SGNL	Common Stock	A - Award	D			5,000			5,000
2015-08-05	2015-08-04	4	SEYMOUR TAMARA A	SGNL	Restricted Stock Units	M - Exercise	D			-23,000		69,000
2015-08-05	2015-08-04	4	SEYMOUR TAMARA A	SGNL	Common Stock	F - Taxes	D		1.5600	-8,522	-13		14,478
2015-08-05	2015-08-04	4	SEYMOUR TAMARA A	SGNL	Common Stock	M - Exercise	D			23,000			23,000
2015-07-21	2015-07-17	4	Smith Robin L	SGNL	Restricted Stock Units	M - Exercise	D			-1,375		4,125
2015-07-21	2015-07-17	4	Smith Robin L	SGNL	Common Stock	M - Exercise	D			1,375			1,375
2015-07-21	2015-07-17	4	Schuling Douglas A	SGNL	Restricted Stock Units	M - Exercise	D			-1,375		4,125
2015-07-21	2015-07-17	4	Schuling Douglas A	SGNL	Common Stock	M - Exercise	D			1,375			1,375
2015-07-21	2015-07-17	4	Gonyer David A	SGNL	Restricted Stock Units	M - Exercise	D			-1,375		4,125
2015-07-21	2015-07-17	4	Gonyer David A	SGNL	Common Stock	M - Exercise	D			1,375			1,375
2015-06-23	2015-06-19	4	Riccitelli Samuel D	SGNL	Restricted Stock Units	M - Exercise	D			-124,252		248,503
2015-06-23	2015-06-19	4	Riccitelli Samuel D	SGNL	Common Stock	F - Taxes	D		1.5100	-46,036	-70		331,130
2015-06-23	2015-06-19	4	Riccitelli Samuel D	SGNL	Common Stock	M - Exercise	D			124,252			377,166
2015-04-10	2015-04-08	4	Riccitelli Samuel D	SGNL	Restricted Stock Units	M - Exercise	D			-372,756		372,755
2015-04-10	2015-04-08	4	Riccitelli Samuel D	SGNL	Common Stock	F - Taxes	D		2.0800	-119,842	-249		252,914
2015-04-10	2015-04-08	4	Riccitelli Samuel D	SGNL	Common Stock	M - Exercise	D			372,756			372,756
2014-08-04	2014-08-04	4	SEYMOUR TAMARA A	SGNL	Restricted Stock Units	A - Award	D			92,000		92,000
2014-07-21	2014-07-17	4	Smith Robin L	SGNL	Restricted Stock Units	A - Award	D			5,500		5,500
2014-07-21	2014-07-17	4	Smith Robin L	SGNL	Stock Option (right to buy)	A - Award	D	5.60		6,000		6,000
2014-07-21	2014-07-17	4	Gonyer David A	SGNL	Restricted Stock Units	A - Award	D			5,500		5,500
2014-07-21	2014-07-17	4	Gonyer David A	SGNL	Stock Option (right to buy)	A - Award	D	5.60		6,000		6,000
2014-07-21	2014-07-17	4	Schuling Douglas A	SGNL	Restricted Stock Units	A - Award	D			5,500		5,500
2014-07-21	2014-07-17	4	Schuling Douglas A	SGNL	Stock Option (right to buy)	A - Award	D	5.60		6,000		6,000
2014-06-17		3	LEBOW ALPHA, LLLP By LeBow Alpha, LLLP	SGNL	Common Stock, par value $0.01 per share		I						4,465,258
2014-06-17		3	LEBOW ALPHA, LLLP By LeBow Alpha, LLLP	SGNL	Common Stock, par value $0.01 per share		I						4,465,258
2014-06-17		3	LEBOW ALPHA, LLLP By LeBow Alpha, LLLP	SGNL	Common Stock, par value $0.01 per share		I						4,465,258

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각

자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득

파생상품 전환

자사에게 유가증권을 매각 또는 양도

기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급

내부자에 의한 또는 내부자에게 증권 증여

지분스왑 및 유사 위험 회피거래

자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환

보고서 양식 4에 자진 신고된 거래

기타 (거래 내용을 설명하는 각주와 동반)

DE:1S1	€14.00
GB:0K1R	US$16.32

VRDN / Viridian Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5